PT Mitra Keluarga Karyasehat Tbk (ISX:MIKA) Research & Development: Rp0 Mil (TTM As of Mar. 2026)


ISX:MIKA PT Mitra Keluarga Karyasehat Tbk ISX:MIKA
82 GF Score
Price Rp1,700.00
GF Value Rp3,236.89
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Mitra Keluarga Karyasehat Tbk Research & Development?

PT Mitra Keluarga Karyasehat Tbk ISX:MIKA -2.02% 82 Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:MIKA with a GF Score™ of 82/100 and a GF Value™ of Rp3,236.89 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Mitra Keluarga Karyasehat Tbk's Research & Development for the three months ended in Mar. 2026 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.

PT Mitra Keluarga Karyasehat Tbk  (ISX:MIKA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Mitra Keluarga Karyasehat Tbk Research & Development Related Terms

PT Mitra Keluarga Karyasehat Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Mitra Keluarga Karyasehat Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Mitra Keluarga Karyasehat Tbk Research & Development Chart

PT Mitra Keluarga Karyasehat Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PT Mitra Keluarga Karyasehat Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:MIKA
82GF Score
PT Mitra Keluarga Karyasehat Tbk ISX:MIKA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Mitra Keluarga Karyasehat Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT Mitra Keluarga Karyasehat Tbk (ISX:MIKA) has a Research & Development of Rp0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT Mitra Keluarga Karyasehat Tbk and its competitors.
Is PT Mitra Keluarga Karyasehat Tbk's Research & Development too high?
PT Mitra Keluarga Karyasehat Tbk's current Research & Development is Rp0 Mil. Overall, PT Mitra Keluarga Karyasehat Tbk has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Mitra Keluarga Karyasehat Tbk's Research & Development compare to HCA and THC?
PT Mitra Keluarga Karyasehat Tbk's Research & Development of Rp0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Mitra Keluarga Karyasehat Tbk and its competitors. PT Mitra Keluarga Karyasehat Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Mitra Keluarga Karyasehat Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Mitra Keluarga Karyasehat Tbk (ISX:MIKA) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp3,236.89, compared to a current price of Rp1,700.00 — trading 47.5% below its estimated fair value. The current Research & Development is Rp0 Mil. PT Mitra Keluarga Karyasehat Tbk's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Mitra Keluarga Karyasehat Tbk (ISX:MIKA), the current Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Mitra Keluarga Karyasehat Tbk (ISX:MIKA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Mitra Keluarga Karyasehat Tbk stock appears to be undervalued. The current stock price of Rp1,700.00 is trading 47.5% below its estimated GF Value™ of Rp3,236.89. GuruFocus considers PT Mitra Keluarga Karyasehat Tbk to be Significantly Undervalued.

Key valuation signals for ISX:MIKA:

  • Research & Development: Rp0 Mil
  • GF Value™: Rp3,236.89 vs. price of Rp1,700.00 (47.5% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the ISX:MIKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Mitra Keluarga Karyasehat Tbk Business Description

Address Jalan Bukit Gading Raya Kav. 2, Kelapa Gading, Jakarta, IDN, 14240
PT Mitra Keluarga Karyasehat Tbk operates a hospital network providing Outpatient and inpatient healthcare services. It has facilities for oncology and radiotherapy, brain and spine care, women and children's health, and orthopedic care. It operates in two segments, namely the Outpatient and Inpatient segments. The Inpatient segments derive the majority of the revenue.
82GF Score

Get the complete analysis for ISX:MIKA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,700.00
Price
Rp3,236.89
GF Value